Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/15338
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wattanasirichaigoon S. | |
dc.contributor.author | Tasanakhajorn U. | |
dc.contributor.author | Jesadapatarakul S. | |
dc.date.accessioned | 2021-04-05T04:33:35Z | - |
dc.date.available | 2021-04-05T04:33:35Z | - |
dc.date.issued | 1998 | |
dc.identifier.issn | 1252208 | |
dc.identifier.other | 2-s2.0-0032062789 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/15338 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032062789&partnerID=40&md5=d1a73444f83e7944b2472d75ec16b6c1 | |
dc.description.abstract | In the study, to analyse a K-ras oncogene mutated at codon 12 in 24 patients with choIangiocarcinomas, four (16.67%) of them contained this point mutation. One of 4 was peripheral and the others were hilar tumors. There was no significant relationship between mutation and clinical features in terms of age, sex, endemic area, tumor location, tumor grading and pathological features. In our study, the incidence of K-ras codon 12 mutation in Thai patients with cholangiocarcinoma was lower than that found in British and Japanese patients. The discrepancy of incidence and type of the mutations, in different races and environment probably indicates that there is/are different etiologic mechanism(s) in the pathogenesis of cholangiocarcinoma. | |
dc.subject | DNA | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | article | |
dc.subject | bile duct carcinoma | |
dc.subject | bile duct tumor | |
dc.subject | clinical trial | |
dc.subject | codon | |
dc.subject | comparative study | |
dc.subject | confidence interval | |
dc.subject | female | |
dc.subject | genetics | |
dc.subject | human | |
dc.subject | intrahepatic bile duct | |
dc.subject | male | |
dc.subject | middle aged | |
dc.subject | molecular genetics | |
dc.subject | nucleotide sequence | |
dc.subject | oncogene ras | |
dc.subject | point mutation | |
dc.subject | polymerase chain reaction | |
dc.subject | sensitivity and specificity | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Base Sequence | |
dc.subject | Bile Duct Neoplasms | |
dc.subject | Bile Ducts, Intrahepatic | |
dc.subject | Cholangiocarcinoma | |
dc.subject | Codon | |
dc.subject | Confidence Intervals | |
dc.subject | DNA, Neoplasm | |
dc.subject | Female | |
dc.subject | Genes, ras | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Molecular Sequence Data | |
dc.subject | Point Mutation | |
dc.subject | Polymerase Chain Reaction | |
dc.subject | Sensitivity and Specificity | |
dc.title | The Incidence of K-ras Codon 12 Mutations in Cholangiocarcinoma Detected by Polymerase Chain Reaction Technique | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of the Medical Association of Thailand. Vol 81, No.5 (1998), p.316-322 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.